mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.07 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.084 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.08 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.08 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |